Daily Cosmetic Research Analysis
Analyzed 24 papers and selected 3 impactful papers.
Summary
A double-blinded RCT found a botanical anti-inflammatory moisturizer outperformed 0.75% metronidazole for rosacea over 12 weeks. A methodological study prospectively validated a toxicokinetic read-across workflow for cosmetic ingredients, enabling human TK predictions with minimal new data. National U.S. data identified high sunburn prevalence and common contexts, with over half occurring despite sunscreen use, informing targeted photoprotection strategies.
Research Themes
- Cosmeceutical therapeutics for inflammatory dermatoses
- Non-animal safety assessment and toxicokinetics of cosmetic ingredients
- Photoprotection behaviors and targeted prevention
Selected Articles
1. Efficacy, Tolerance, and Safety of a Novel Botanical Anti-Inflammatory Moisturizer in Rosacea: Results From a Double-Blinded, Randomized Controlled Trial.
In a 12-week double-blind RCT (n=60), a topical oat and aloe anti-inflammatory moisturizer produced significantly greater reductions in erythema (IGA) and inflammatory lesion counts than 0.75% metronidazole at Weeks 8 and 12, with no tolerability issues. Findings suggest a barrier-supportive, botanical approach can outperform a standard antibiotic cream in rosacea.
Impact: This head-to-head randomized trial indicates a non-antibiotic, botanical moisturizer can surpass metronidazole for rosacea, potentially shifting first-line topical strategies and reducing antibiotic reliance.
Clinical Implications: Consider the botanical anti-inflammatory moisturizer as a first-line or adjunct topical for mild-to-moderate rosacea, particularly to address erythema and papulopustular lesions, while reducing antibiotic exposure.
Key Findings
- At Week 8, erythema IGA reduction was 50% with the moisturizer vs 22% with metronidazole (p=0.001).
- At Week 8, inflammatory lesion counts decreased 74% with the moisturizer vs 6% with metronidazole (p=0.015).
- At Week 12, erythema IGA reduction was 54% vs 23% (p<0.001) and lesion reduction 74% vs 17% (p=0.044) favoring the moisturizer.
- No tolerability issues were reported for either product.
Methodological Strengths
- Double-blinded randomized controlled, active-comparator design
- Clinically relevant endpoints (erythema IGA, inflammatory lesion counts) assessed at multiple timepoints
Limitations
- Single RCT with modest sample size (n=60) and 12-week duration
- Conducted in a single specialty context; generalizability and long-term relapse not assessed
Future Directions: Conduct larger, multicenter trials comparing against other standards (e.g., ivermectin, brimonidine), assess durability and relapse, and explore mechanisms of anti-inflammatory action.
BACKGROUND: Rosacea is characterized by facial erythema that can be resistant to improvement. AIMS: This research evaluated the efficacy and tolerability of a topical anti-inflammatory moisturizer containing oat and aloe as compared to 0.75% metronidazole cream over 12 weeks. METHODS: This double-blinded, randomized, controlled trial enrolled 60 adults with mild-to-severe rosacea, randomized to either the study anti-inflammatory moisturizer or 0.75% metronidazole cream daily for 12 weeks. Participants were evaluated at baseline and Weeks 4, 8, and 12. Efficacy was measured by investigator global assessment (IGA) of erythema and inflammatory lesion counts. Tolerability was assessed by the investigator and subjects. RESULTS: Both study products demonstrated similar IGA scores at Week 4. By Week 8, the study oat and aloe anti-inflammatory moisturizer demonstrated significantly greater reduction in both erythema IGA (50% vs. 22%, p = 0.001) and lesion counts (74% vs. 6%, p = 0.015). At the conclusion of the 12-week study, the anti-inflammatory moisturizer produced a reduction in IGA erythema of 54% vs. 23% (p < 0.001) and a reduction in inflammatory lesion counts of 74% vs. 17% (p = 0.044). No tolerability issues were noted. CONCLUSIONS: The oat and aloe anti-inflammatory moisturizer was superior and outperformed 0.75% metronidazole cream in both erythema and lesion reduction in rosacea subjects after 8 and 12 weeks of treatment.
2. Development and Prospective Validation of a Read-Across Approach to Assess the In Vivo Toxicokinetic Profiles of Chemicals in Humans.
A structured TK read-across workflow for cosmetic ingredients was developed and prospectively validated. "Suitable" analog pairs showed TK alignment within 0.5–2-fold, while less suitable categories deviated as predicted; a human study confirmed terpinolene TK aligned with limonene within two-fold.
Impact: Provides an evidence-based, prospectively validated method to predict human TK for cosmetic ingredients, reducing reliance on new in vivo testing and enabling more efficient safety assessment.
Clinical Implications: Enhances regulatory and safety decision-making for cosmetic ingredients by supporting TK predictions from well-justified analogs, informing exposure limits and product safety without extensive new human or animal data.
Key Findings
- A TK analog workflow with suitability ratings (structure, reactivity, metabolism, physicochemical properties) was established.
- “Suitable” analog pairs showed comparable in vivo TK and in vitro ADME, typically within 0.5–2-fold.
- “Suitable with interpretation” pairs deviated >2-fold; “suitable with pre-condition” pairs often differed >5-fold in clearance.
- Prospective human data showed terpinolene TK aligned within two-fold of limonene.
Methodological Strengths
- Prospective human validation of the read-across prediction
- Transparent, criteria-based analog suitability ratings integrating in vitro and in vivo ADME/TK evidence
Limitations
- Limited number of human validation cases; external generalizability across chemical classes requires expansion
- Accuracy depends on correctly characterizing structural and metabolic similarity; misclassification can mislead TK inference
Future Directions: Scale up validation across diverse chemical spaces and routes, integrate PBPK modeling and uncertainty quantification, and promote data/code sharing for regulatory uptake.
The use of read-across is established for assessing toxicological hazards based on structural and biological similarities. Toxicokinetic (TK) read-across extends this concept to infer in vivo TK of target compounds from source analogs with available data, but its application to non-pharmaceutical chemicals remains limited. Here, we evaluated TK read-across for non-pharmaceutical compounds, focusing on cosmetic ingredients across multiple administration routes and diverse TK properties, including poor oral bioavailability. A TK analog workflow was applied to identify analogs, with suitability ratings assigned based on structure, reactivity, metabolism, and physicochemical properties. Case studies showed that "suitable" pairs exhibited comparable in vivo TK and in vitro absorption, distribution, metabolism and excretion (ADME) characteristics, typically within 0.5-2-fold differences. Pairs rated "suitable with interpretation" displayed >2-fold TK differences, consistent with structural or ADME dissimilarities. "Suitable with pre-condition" pairs were poor TK analogs, as analogs were often metabolites or metabolic precursors of targets, with >5-fold differences in clearance. "Not suitable" pairs showed divergent TK profiles and structures. A human study using a "suitable" pair demonstrated that terpinolene TK aligned with limonene data within two-fold. Overall, this workflow supports evidence-based analog selection and enables TK read-across to inform safety and TK assessments when human data are limited.
3. Prevalence and Context of Sunburn Among U.S. Adults - United States, 2024.
In 2024 NHIS data, 35.1% of U.S. adults had ≥1 sunburn and 7.5% had ≥4. The most common context was being in/on/near water (60.6%), followed by exercising (24.7%) and drinking alcohol (17.6%); 55.1% reported their most recent sunburn occurred despite using sunscreen.
Impact: Identifies high-prevalence contexts for sunburn to refine public health messaging and interventions, highlighting the limitations of sunscreen-only strategies.
Clinical Implications: Counsel patients on multi-modal photoprotection (UPF clothing, shade, scheduling, water-resistant sunscreen with reapplication), prioritizing high-risk contexts like water activities, outdoor exercise, and alcohol use.
Key Findings
- An estimated 35.1% of U.S. adults had ≥1 sunburn; 7.5% had ≥4 in the prior 12 months.
- Most recent sunburn most often occurred in/on/near water (60.6%), followed by exercising (24.7%) and drinking alcohol (17.6%).
- 55.1% reported their most recent sunburn occurred despite using sunscreen.
- Work-related sunburn accounted for 12.9%; intentional tanning for 15.9%.
Methodological Strengths
- Nationally representative NHIS dataset with standardized questions
- Context-specific reporting enabling targeted prevention insights
Limitations
- Self-reported data subject to recall and social desirability bias
- Cross-sectional design precludes causal inference
Future Directions: Develop and evaluate interventions tailored to high-risk contexts (e.g., water activities), and test strategies to improve sunscreen reapplication and complementary protective behaviors.
Sunburn is an important risk factor for skin cancer. Understanding sunburn prevalence and the contexts in which sunburn commonly occurs might help guide the development and implementation of sun safety interventions. Data from the 2024 National Health Interview Survey sample adult questionnaire were analyzed to describe the prevalence of one or more and four or more sunburns among U.S. adults during the previous 12 months and the percentages of U.S. adults who experienced their most recent sunburn while they were working at their job; intentionally tanning; exercising; spending time in, on, or near water; using sunscreen; or drinking alcohol. Overall, an estimated 88.1 million (35.1%) U.S. adults had at least one sunburn during the previous 12 months, and 18.8 million (7.5%) had four or more sunburns. Among adults who experienced sunburn during the previous year, spending time in, on, or near the water was the most frequently reported context of their most recent sunburn (60.6%); followed by exercising (24.7%); drinking alcohol (17.6%); intentionally tanning (15.9%); and working at their job (12.9%). Approximately one half (55.1%) of respondents reported that their most recent sunburn occurred despite using sunscreen. These findings can help guide research and activities to adapt, tailor, and expand evidence-based interventions to improve use of sun protection, prevent sunburn, and reduce skin cancer risk.